Okay. Thanks, Michael. Regarding the take rate in Q4, as mentioned in our CFO's remark, it's due to both product mix as well as the investor side management fee to be sturdy, given it's AUM-driven, and of course, there's also certain adjustments due to the borrowers' behavior in terms of early repayment that also helped a bit pushing the take rate upward to the 22%. I think if you're looking forward, we expect the product mix continue to be healthy, the investor side of service revenue continue to be sturdy. So probably, if you were to model our business, a 20% also hit rate forward is a reasonable number that you can use for. In terms of the business in our Q1, it's coming to the end. We're still tightening all the numbers. Given the overall environment, we are pretty prudent in terms of controlling the business volume, particularly on the loan origination side. And at the same time, we have also been very prudent and diligent in terms of overall cost control structures. So we're still looking at the business. And our business, even though we had quite some fixed component in our cost, but given some of the recurring revenue stream, as well as our optimized, rationalized cost base and capacity, we're still looking for a reasonable quarter. From the regulation perspective, as Ning has mentioned, we're pursuing multiple paths in terms of extending, developing our credit business. From the capital requirement perspective, we already have 1 billion of [regis] capital in place. And also, for various license, we're comfortable in terms of meeting the requirement when we apply for those licenses. From the contingent liability cancellation, it was a good help or a good value for our Yiren Digital. Because the volatility and the business slowdown, CreditEase has waived the remaining cash payment for the business realignment. And then there's a pure balance sheet impact. There's no P&L impact. It's just that the remaining cash payment was completely waived. I hope that answered your question.